ISSN : 1301-5680
e-ISSN : 2149-8156
Turkish Journal of Thoracic and Cardiovascular Surgery     
Subcutaneous use of treprostinil in pediatric pulmonary hypertension patients: A report of three cases
Akif Kavgacı1, Serdar Kula1, Fatma İncedere1, Semiha Terlemez1, Fatma Sedef Tunaoğlu1
1Department of Pediatrics, Division of Pediatric Cardiology, Gazi University Faculty of Medicine, Ankara, Türkiye
DOI : 10.5606/tgkdc.dergisi.2023.23748
Treprostinil was approved by the United States Food and Drug Administration for use in the treatment of pulmonary arterial hypertension in 2002. Intravenous or subcutaneous treprostinil is used in pulmonary arterial hypertension patients in the functional classes of II-IV to alleviate exercise-related symptoms, or in cases where epoprostenol treatment should be reduced due to side effects. In this article, we describe three pediatric cases of pulmonary arterial hypertension in whom subcutaneous treprostinil was used.
Keywords : Pulmonary arterial hypertension, subcutaneous, treprostinil
Viewed : 1455
Downloaded : 401